Apple is expanding GPU-accelerated AI capabilities on its chips, with multiple projects demonstrating local LLM inference and context memory optimization specifically for Apple Silicon. This shift toward on-device processing directly addresses healthcare's privacy and latency requirements, eliminating cloud dependencies for AI agent operations. For clinical workflows, on-device inference means faster clinical decision support without external data transmission, reducing compliance friction around patient data. Healthcare vendors should evaluate Apple Silicon deployment as an alternative to cloud-dependent AI infrastructure, particularly for EHR integrations and point-of-care applications where data residency matters.